30 results
POS AM
IPIX
Innovation Pharmaceuticals Inc.
17 Oct 19
Prospectus update (post-effective amendment)
5:23pm
discontinued, we may be fined, we or our investigators may be precluded from conducting any ongoing or any future clinical trials, the government may
424B3
77ouvydjpgk3j3xj
22 Nov 13
Prospectus supplement
12:00am